Avexima Racing Cars

On September 8, 2024, Avexima held a special event for its partners at the Moscow Raceway circuit in the Moscow region, which at that time was hosting another stage of the Russian Endurance Challenge (REC) racing season.

The presentation of the capabilities of the Russian pharmaceutical company Avexima -  capabilities that ensure the stability of current operations and development plans, shaping the company's future potential as one of the leaders of the Russian pharmaceutical market  - was delivered by Commercial Director Yuri Karpenko and Head of the Marketing Department Valeriya Kilochek.

«Being here at the race track, we can draw a parallel between supercar racing and the pharmaceutical market. Both require technical excellence, experience, reaction to ongoing changes, confidence in victory, and a drive to lead. One of these racing cars conquering the steep turns of the sports track is named Nobazit Forte and has every opportunity to become a leader not only in this race but also the potential to become a leader among medications used in the treatment of influenza and ARVI. We have every opportunity to achieve this goal», noted Avexima's General Director Ivan Khalepo in his speech.

Avexima has been a sponsor of the Russian racing team Capital RT for several years. The team's drivers have repeatedly been among the winners of Russian and international circuit races.

As part of the event, partners of the Avexima company received an exclusive opportunity to see how a racing team operates, visit the technical garages, walk along the track's starting grid, and experience the full power of the GT Pro-class racing car Nobazit Forte by riding several laps as a passenger. They also participated in a quiz from brand managers testing their knowledge of the main products of JSC Avexima. Of course, the thrilling four-hour battle on the track captivated everyone in attendance.